Spine care center has new care model, in-house specialists

Weill Cornell Medicine's new Center for Comprehensive Spine Care exemplifies a different philosophy, offering patients centralized, multidisciplinary care in one building.

Bacteria links Crohn's disease, arthritis, researchers find

Research published Feb. 8 in Science Translational Medicine helps explain the connection between Crohn's disease and arthritis.

Collaborators use new strategies to study cancer's spread

Finding new ways to study cancer and how it spreads is the goal of the Center on the Physics of Cancer Metabolism, a new translational research program between the College of Engineering and Weill Cornell Medicine.

Cornell Tech Runway Program postdoc wins $250,000

A participant in the Runway Program at the Jacobs Technion-Cornell Institute of Cornell Tech in New York City has won a $250,000 prize in the second 76West Clean Energy Competition.

Cornell Tech, eLab startup Datalogue raises $1.5 million

Datalogue, a Cornell startup with roots on the Ithaca and Cornell Tech campuses that uses deep learning and artificial intelligence to automate data preparation, raised $1.5 million in seed funding.

Grant funds conference on reducing food waste

A $280,000 grant form the Rockefeller Foundation will fund a Cornell-led workshop in New York City for business leaders to explore strategies to reduce food waste and loss through new products and services.

Weill Cornell lab helps translate ideas into innovations

The Dean's Entrepreneurship Lab provides resources and education opportunities to students and faculty who have ideas with commercial potential that they want to translate from the lab to the patient.

Two Sigma to be first tenant at The Bridge at Cornell Tech

Forest City Ratner Cos. announced Jan. 23 that Two Sigma Investments, a tech and investment firm, is the first company to be selected to locate at The Bridge at Cornell Tech.

New technique improves blood flow to damaged tissues

A gene essential for making blood vessels in embryos can successfully transform amniotic cells into therapeutic blood vessel cells, according to new research from Weill Cornell Medicine.